Codexis
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2002-01-01
- Employees
- 174
- Market Cap
- $212.7M
- Website
- http://www.codexis.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Study of the Safety and Tolerability of CDX-6114 in Healthy Volunteers
- First Posted Date
- 2019-01-09
- Last Posted Date
- 2021-08-04
- Lead Sponsor
- Codexis Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT03797664
- Locations
- 🇦🇺
Linear Clinical Services, Perth, Western Australia, Australia
Safety and Tolerability of CDX-6114 in Healthy Volunteers
- First Posted Date
- 2018-07-05
- Last Posted Date
- 2018-09-20
- Lead Sponsor
- Codexis Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT03577886
- Locations
- 🇦🇺
Linear Clinical Services, Perth, Western Australia, Australia
News
No news found